El año pasado, Abbott Laboratories generó 8.00B USD en su segmento con mejor rendimiento, Diabetes Care. United States realizó la mayor aportación, representando 17.13B USD el año pasado. Para el último trimestre, Abbott Laboratories reportó unos ingresos de 2.19B USD para el periodo finalizado el 2026-06-30, procedentes del segmento con mejor rendimiento, Diabetes Care. All other Countries aportó los mayores ingresos, alcanzando los 7.38B USD.

Por negocio

Ingresos operativos

Proporción

Anual

Anual

Trimestral

Diabetes Care

Core Laboratory

Adult Nutritionals

Key Emerging Markets

Pediatric Nutritionals

Vascular

Electrophysiology

Rhythm Management

Structural Heart

Rapid Diagnostics

Heart Failure

Other

Neuromodulation

Point of Care

Molecular

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

Diabetes Care

8.00B(18.04%)

6.80B(16.22%)

5.76B(14.36%)

4.76B(10.90%)

4.33B(10.05%)

3.27B(9.44%)

Core Laboratory

5.36B(12.09%)

5.24B(12.48%)

5.16B(12.86%)

4.89B(11.20%)

5.13B(11.90%)

4.47B(12.93%)

Adult Nutritionals

4.48B(10.10%)

4.39B(10.46%)

4.22B(10.52%)

3.98B(9.11%)

4.00B(9.28%)

3.52B(10.17%)

Key Emerging Markets

4.17B(9.40%)

3.86B(9.20%)

3.81B(9.49%)

3.73B(8.54%)

3.54B(8.22%)

3.21B(9.27%)

Pediatric Nutritionals

3.97B(8.96%)

4.02B(9.59%)

3.93B(9.81%)

3.48B(7.97%)

4.30B(9.98%)

4.13B(11.92%)

Vascular

3.00B(6.76%)

2.84B(6.76%)

2.68B(6.68%)

2.48B(5.69%)

2.65B(6.16%)

2.34B(6.76%)

Electrophysiology

2.76B(6.24%)

2.47B(5.88%)

2.19B(5.47%)

1.93B(4.41%)

1.91B(4.43%)

1.58B(4.56%)

Rhythm Management

2.65B(5.98%)

2.39B(5.70%)

2.25B(5.62%)

2.12B(4.85%)

2.20B(5.10%)

1.91B(5.53%)

Structural Heart

2.52B(5.69%)

2.25B(5.35%)

1.94B(4.85%)

1.71B(3.92%)

1.61B(3.74%)

1.25B(3.60%)

Rapid Diagnostics

2.45B(5.54%)

3.00B(7.14%)

3.69B(9.20%)

10.18B(23.31%)

8.55B(19.86%)

4.38B(12.64%)

Heart Failure

1.45B(3.27%)

1.28B(3.05%)

1.16B(2.89%)

920.00M(2.11%)

889.00M(2.06%)

740.00M(2.14%)

Other

1.39B(3.13%)

1.35B(3.22%)

1.27B(3.17%)

1.20B(2.74%)

1.23B(2.86%)

1.16B(3.35%)

Neuromodulation

1.01B(2.28%)

962.00M(2.29%)

890.00M(2.22%)

770.00M(1.76%)

781.00M(1.81%)

702.00M(2.03%)

Point of Care

606.00M(1.37%)

588.00M(1.40%)

565.00M(1.41%)

525.00M(1.20%)

536.00M(1.24%)

516.00M(1.49%)

Molecular

517.00M(1.17%)

521.00M(1.24%)

574.00M(1.43%)

995.00M(2.28%)

1.43B(3.31%)

1.44B(4.16%)

Por región

Ingresos operativos

Proporción

Anual

Anual

Trimestral

United States

All other Countries

Germany

China

India

Switzerland

Japan

United Kingdom

India

The Netherlands

Canada

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

United States

17.13B(38.63%)

16.32B(38.91%)

15.45B(38.53%)

18.14B(41.56%)

16.64B(38.63%)

13.02B(37.63%)

11.40B(35.73%)

All other Countries

15.98B(36.05%)

14.85B(35.39%)

14.08B(35.11%)

14.84B(34.00%)

15.52B(36.02%)

12.58B(36.35%)

11.53B(36.15%)

Germany

2.76B(6.22%)

2.54B(6.05%)

2.35B(5.85%)

2.34B(5.36%)

2.57B(5.97%)

2.11B(6.09%)

1.75B(5.49%)

China

1.91B(4.30%)

2.11B(5.04%)

2.25B(5.62%)

2.13B(4.89%)

2.39B(5.55%)

1.97B(5.68%)

2.35B(7.35%)

India

1.87B(4.22%)

--(--)

Switzerland

1.87B(4.22%)

1.75B(4.16%)

1.64B(4.08%)

1.34B(3.06%)

1.31B(3.05%)

1.14B(3.29%)

1.07B(3.35%)

Japan

1.48B(3.33%)

1.44B(3.44%)

1.51B(3.77%)

1.93B(4.43%)

1.70B(3.93%)

1.39B(4.00%)

1.44B(4.50%)

United Kingdom

1.34B(3.02%)

--(--)

India

--(--)

1.82B(4.33%)

1.75B(4.36%)

1.65B(3.78%)

1.56B(3.62%)

1.32B(3.82%)

1.40B(4.38%)

The Netherlands

--(--)

1.12B(2.68%)

1.07B(2.68%)

--(--)

1.08B(3.13%)

975.00M(3.06%)

Canada

--(--)

1.28B(2.93%)

1.39B(3.22%)

--(--)